High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent Inhibitor

Publication forthcoming<br>For Scientific and Technical Information Only For All InformationUnless otherwise indicated, this information has been authored by an employee or employees of UChicago Argonne, LLC., operator of Argonne National Laboratory, with the U.S. Department of Energy. The U.S. Government has rights to use, reproduce, and distribute this information. The public may copy and use this information without charge, provided that this Notice and any statement of authorship are reproduced on all copies.While every effort has been made to produce valid data, by using this data, User acknowledges that neither the Government nor operating contractors of the above national laboratories makes any warranty, express or implied, of either the accuracy or completeness of this information or assumes any liability or responsibility for the use of this information. Additionally, this information is provided solely for research purposes and is not provided for purposes of offering medical advice. Accordingly, the U.S. Government and operating contractors of the above national laboratories are not to be liable to any user for any loss or damage, whether in contract, tort (including negligence), breach of statutory duty, or otherwise, even if foreseeable, arising under or in connection with use of or reliance on the content displayed in this report.<br><br><b> </b>

即将出版的出版物<br>仅用于科技信息。除非另有说明，所有信息均由运营阿贡国家实验室（Argonne National Laboratory）的芝加哥阿贡有限责任公司（UChicago Argonne, LLC.）雇员与美国能源部（U.S. Department of Energy）合作撰写。美国政府拥有使用、复制及分发本信息的权利。公众可免费复制和使用本信息，但需在所有复制品中保留本声明及任何作者归属说明。<br><br>尽管已尽一切努力生成可靠数据，但用户在使用本数据时应知晓，美国政府及上述国家实验室的运营承包商均未就本信息的准确性或完整性作出任何明示或默示的担保，亦不对使用本信息承担任何责任或义务。此外，本信息仅用于科研目的，并非用于提供医疗建议。因此，无论因合同、侵权（包括过失）、违反法定义务或其他情形，即使该损失或损害可预见，美国政府及上述国家实验室的运营承包商均不对任何用户因使用或依赖本报告内容而遭受的任何损失或损害承担责任。<br><br><b> </b>